By: Charles D. Brunt A quarterhorse trainer’s penchant for overusing clenbuterol – a drug used to treat respiratory disease in horses but mimics muscle-building anabolic steroids in higher doses – has earned him the loss of his state racing license for the next four years. Trainer Ramon M. Ochoa, 56, of La Union, had two
By Charles D. Brunt / Journal Staff Writer The New Mexico Racing Commission has sanctioned a racehorse trainer and a horse owner after their horse was found to have almost six times more of a regulated drug in its system than allowed after winning a race at Zia Park. The owner has to give up
by Paulick Report Staff Dr. Mary Scollay, Dr. Rick Arthur, and Dr. Lynn Hovda submitted the following letter to the Paulick Report voicing their support of the RCI’s recent decision to establish rules on compounded medications in horse racing: The Association of Racing Commissioners International (RCI) recently announced they have given approval to a Model
Press Release Faced with continued increases in the number of reported clenbuterol overages in racehorses across the nation, the American Quarter Horse Association is taking steps for the safety and welfare of the horse and rider and is announcing that beginning January 1, 2016, clenbuterol, in any form, is banned from use in any type
NEWS RELEASE December 3, 2013 Contact: Hallie Roach Lewis (859) 224-2848 RMTC: CURRENT THRESHOLD LEVELS FOR CORTICOSTEROIDS, CLENBUTEROL SHOULD REMAIN The Racing Medication & Testing Consortium (RMTC) is releasing two position papers which stated that no physiologic difference among the various racing breeds exists to justify changing regulatory thresholds from those recently established by the
NEWS RELEASE November 15, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD MAKES THERAPEUTIC WITHDRAWAL RECOMMENDATIONS, ANNOUNCES UPCOMING CORTICOSTEROIDS CONFERENCE At its November 13 meeting in Louisville, Kentucky, the Racing Medication and Testing Consortium (RMTC) board of directors addressed a number of important initiatives including therapeutic medications, laboratory proficiency, corticosteroid regulation and penalties for rule
NEWS RELEASE April 24, 2012 Contact: Hallie Lewis (859) 224-2848 RMTC BOARD NAMES INTERIM EXECUTIVE DIRECTOR, RECEIVES UPDATES ON DRUG ADMINISTRATION STUDIES AND MAKES THRESHOLD LEVEL RECOMMENDATION At its April 23 meeting in Dallas, Texas, the Racing Medication and Testing Consortium (RMTC) board of directors approved an agreement with The Jockey Club to engage the
February 22, 2007 During its meeting on Wednesday, February 21, at The Westin Tampa Harbour Island hotel the board of directors of the Racing Medication and Testing Consortium (RMTC) passed a model rule on anabolic steroids that will be forwarded to the Association of Racing Commissioners International (RCI) for approval during the RCI Annual Convention
February 8, 2006-The Board of Directors of the Racing Medication and Testing Consortium (RMTC) on Tuesday approved a plan developed by Dr. Rick Sams of The Ohio State University to establish guidelines for withdrawal times for therapeutic medications commonly utilized by race track veterinarians. The RMTC board meeting was held in Las Vegas in conjunction
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
